PCM
MGNX icon

Piermont Capital Management’s MacroGenics MGNX Stock Holding History

Piermont Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$714K Buy
56,230
+2,100
+4% +$35.2K 0.34% 105
2018
Q3 		$1.16M Sell
54,130
-12,420
-19% -$265K 0.47% 107
2018
Q2 		$1.37M Buy
+66,550
New +$1.5M 0.42% 106

Other funds holding MGNX

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CP
CPV Partners Stamford, Connecticut $274M AUM 43.74% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Piermont Capital Management's MGNX Position: Q4 2018 in Review

Piermont Capital Management increased its MacroGenics (MGNX) stake by 3.9% in Q4 2018, buying an estimated $35.2K and bringing the position to 56,230 shares worth $714K. The position accounts for 0.34% of the portfolio, ranked #105.

Piermont Capital Management first reported a position in MGNX in Q2 2018 and has held it in 3 quarters since. The position peaked at $1.37M in Q2 2018. 133 funds tracked by Wall St. Rank hold MGNX as of Q4 2018.

  • Piermont Capital Management held 56,230 shares of MacroGenics worth $714K as of Q4 2018.
  • Piermont Capital Management bought 2,100 MacroGenics shares in Q4 2018, an estimated $35.2K.
  • MacroGenics made up 0.34% of Piermont Capital Management's portfolio in Q4 2018, its #105 holding.
  • Piermont Capital Management first reported a position in MacroGenics in Q2 2018 and has held it in 3 quarters since.
  • Piermont Capital Management's MacroGenics position peaked at $1.37M in Q2 2018.
  • 133 funds tracked by Wall St. Rank held MacroGenics as of Q4 2018.

Based on Piermont Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.